ZYBERNO
Stock Report
Updated Sep 1, 2026

ABSCI CORP (ABSI)

NASDAQ

$8.71

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
26.0/100
POOR BUSINESS
ABSCI CORP (ABSI) scores 26/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-59.2%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.05x)
Operating Margin (Operational Efficiency):CRITICAL (-8,084.5%)
Return on Capital (Capital Efficiency):CRITICAL (-60.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

ABSCI CORP (ABSI) stock report — Zyberno Score 26/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, ABSI generated -$98.71M in Owner Earnings. Capital was deployed as follows: $1.11M invested in capital expenditures. Reinvestment rate: 11.2%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:8.71
Market Cap:$1.37B

Valuation Multiples (3)

P/B Ratio:5.57x
P/S Ratio:878.65x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$1.28B

Price Action & Momentum (3)

Momentum Percentile:99 / 100
% of 52-Week High:72.3%
B. Profitability Assessment

Return Metrics (5)

ROA:-52.3%
Reinvestment Rate:11.2%
Fundamental Growth Rate (g):-6.8%

Margin Analysis (3)

Operating Margin Ttm:-8,084.5%
Net Margin Ttm:-7,756.4%
Ebitda Margin:-7,046.7%

TTM Performance (2)

Operating Margin Ttm:-8,084.5%
Net Margin Ttm:-7,756.4%

Yield Metrics (2)

Earnings Yield:-$9.07
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-169.2%
Latest Earnings Filed:2026-08-11

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-37.1%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:10.63x
Quick Ratio:10.63x
Cash Ratio:5.50x

Leverage Analysis (3)

Debt To Equity Ttm:0.05x
Debt-to-Equity Ratio:0.05x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-1,279.97x
Times Interest Earned:-1,279.97

Capital Structure (4)

Working Capital:188,668,000.00
Cash And Cash Equivalents:107,865,000.00
Long Term Debt:$1.64M
Net Debt:-$89.97M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.56M
Linear Growth: -37.1%
📊 Click to view full ABSI Revenue analysis & methodology →
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$126.20M

Bottom Line Performance (3)

-$121.08M
Income Before Tax:-$121.08M
Ebitda Ttm:-109,999,000.00

Operating Expenses (5)

Operating Expenses:127,760,000.00
R And D Expense:86,487,000.00
Sga Expense:35,280,000.00
Income Tax Expense:$127.00K
Interest Expense:94,000.00

Expense Ratios (3)

R And D To Revenue Percentage:27,197.2%
Sga To Revenue Percentage:11,094.3%
Ebitda Margin:-7,046.7%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$268.92M
Current Assets:$208.27M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$40.05M

Liability Structure (4)

Total Liabilities:22,786,000.00
Current Liabilities:19,598,000.00
Long Term Debt:$1.64M
Short Term Debt:$16.26M

Equity & Capital (3)

Equity:$246.13M
Retained Earnings:-$687.59M
Common Stock:17,000.00

Working Capital Items (3)

Accounts Receivable:1,000,000.00
Inventory:0.00
Accounts Payable:7,156,000.00

Special Items (2)

Contract Liabilities:1,400,000.00
Stock Based Compensation:5,245,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$97.39M-$98.51M

Investment Activities (2)

Investing Cash Flow:$7.36M
Capital Expenditures Ttm:1,112,000.00

Financing Activities (3)

Financing Cash Flow:$7.56M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:7,957,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$460.00K

Non-Cash Items (1)

Depreciation Amortization Ttm:16,200,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.79
-$0.79
Earnings Per Share Ttm:-$0.77

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.01
Operating Cash Flow Per Share:-$0.59

Book Value & Capital (2)

Book Value Per Share:$1.56
Cash Per Share:0.68

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.01x
Working Capital Turnover Ttm:0.01x

Receivables Management (2)

Receivables Turnover Ttm:1.56x
Days Sales Outstanding Ttm:233.82

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:1,673.25
Cash Conversion Cycle:-2,438.42
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$98.71M

Damodaran Growth Analysis (2)

Reinvestment Rate:11.2%
Fundamental Growth Rate (g):-6.8%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-37.1%

Other Growth Rates (1)

Book Value Growth Rate (Linear):-10.9%
C. Company Profile & Context

Corporate Information (6)

Symbol:ABSI
Company Name:ABSCI CORP
Sector:Unknown
Industry:Services-Commercial Physical & Biological Research
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:157.47M
Shares Outstanding Basic:157.47M
Shares Outstanding Diluted:157.47M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 02:23:39 UTC
Data Timestamp:2026-09-01T02:23:39.998740
Scroll to Top